Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D03JZQ
|
||||
| Former ID |
DNC010786
|
||||
| Drug Name |
3-(4-phenyl-6-(thiophen-3-yl)pyridin-2-yl)-phenol
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C21H15NOS
|
||||
| Canonical SMILES |
C1=CC=C(C=C1)C2=CC(=NC(=C2)C3=CSC=C3)C4=CC(=CC=C4)O
|
||||
| InChI |
1S/C21H15NOS/c23-19-8-4-7-16(11-19)20-12-18(15-5-2-1-3-6-15)13-21(22-20)17-9-10-24-14-17/h1-14,23H
|
||||
| InChIKey |
GZCPVCLLSOKGCF-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | DNA topoisomerase II | Target Info | Inhibitor | [1] | |
| DNA topoisomerase I | Target Info | Inhibitor | [1] | ||
| WikiPathways | Integrated Pancreatic Cancer Pathway | ||||
| References | |||||
| REF 1 | Bioorg Med Chem. 2010 May 1;18(9):3066-77. Epub 2010 Mar 27.Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study of hydroxylated 2,4-diphenyl-6-aryl pyridines. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.